A single-stage, off-the-shelf solution for knee cartilage and osteochondral defects, with or without mild to moderate osteoarthritis (KL 0-3) comprised of a proprietary biomaterial that is porous and biocompatible.
Derived from a naturally occurring calcium carbonate known as aragonite, the CARTIHEAL Implant is a biphasic scaffold for cartilage repair and subchondral bone restoration.
Shown to deliver clinically meaningful improvements in pain, function and quality of life,*4,5 the CARTIHEAL Implant is the only device approved for the treatment of knee cartilage and osteochondral defects in patients with or without mild to moderate osteoarthritis (KL 0-3).1
The CARTIHEAL Implant is designed to help the body repair knee cartilage and restore damaged bone;2-5 shown to be largely resorbed by the body within 18 months.3,4,6
Deepen your understanding of the intra-operative workflow and instrumentation for the CARTIHEAL Implant's single-stage procedure.
By joining our email list, you can receive all the latest updates, podcasts, clinical evidence and press releases for the CARTIHEAL Implant. Sign up now!
The MyKneeHealth Patient Access Program will facilitate your patient’s access to treatment through the submission of comprehensive requests for prior authorization and internal patient-based appeals, up to and including an external review.
By enrolling in the MyKneeHealth Patient Access Program providers receive assistance with benefit verification and appeals for denied authorizations and claims.
To learn more about our S+N Sports Medicine portfolio, please visit our Knee Repair Page on VuMedi.
* Over 2 and 4 yr follow-up; standard of care = microfracture or debridement.
** Illustration only; not an actual representation.
Products may not be available in all markets because product availability is subject to the regulatory and/or medical practices in individual markets. Please contact your Smith+Nephew representative or distributor if you have questions about the availability of Smith+Nephew products in your area.